Candel Therapeutics CADL Cash Flow Statement (2020-2026)

NASDAQ CADL
$8.37 -0.27 (-3.13%)
As of: Oct 21, 2026 · 3:55 PM EDT
Reported Financials

Candel Therapeutics Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Candel Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 24 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-17.08M-16.16M1.60M-0.87M-4.15M-8.69M-5.08M-8.80M-9.61M-8.44M-11.10M-8.22M-22.24M-10.65M-14.07M7.38M-4.80M-11.27M-29.50M-26.65M
Depreciation and DepletionDep. & Depletion
0.24M0.23M0.20M0.20M0.29M0.30M0.20M0.20M0.26M0.25M0.20M0.20M0.15M0.20M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.03M0.08M0.10M0.08M0.08M0.08M0.08M0.09M0.08M0.07M0.06M0.05M0.04M0.03M0.02M0.26M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.02M0.18M0.17M0.19M0.20M0.18M0.23M0.24M0.20M0.29M0.30M0.20M0.20M0.26M0.25M0.20M0.20M0.15M0.20M
Share-based CompensationStock Comp.
1.07M1.91M-0.45M0.49M0.44M0.74M0.63M0.73M0.73M0.69M0.94M1.04M1.84M1.18M1.24M0.31M1.05M1.16M1.29M2.86M
Gains from Sales and DivestituresGains Divest
-0.07M0.00M0.00M-0.30M0.03M
Asset Writedowns and ImpairmentWritedown
0.23M0.04M0.00M0.01M
Other non-cash itemsOther Non-Cash
12.37M8.25M-9.18M-8.22M-4.97M-0.37M-2.67M-0.64M-0.14M-0.58M0.57M0.09M13.34M1.64M5.93M-14.77M-5.69M-1.15M13.64M12.28M
Change in Working Capital
Change in Account PayablesChange Payables
-0.35M0.18M0.67M-0.58M0.42M-0.51M-0.54M0.15M-0.06M-0.21M0.17M0.05M-0.04M-0.14M-0.06M0.51M1.01M-0.74M0.03M
Change in Accured ExpensesChange Accured Exp.
0.05M0.81M0.72M0.09M0.19M0.55M0.44M-1.79M0.63M-0.09M0.95M-1.58M0.44M1.35M0.54M-2.37M1.13M1.21M2.29M
Change in Other Operating AssetsOther Assets Change
0.02M1.87M-0.26M-0.98M-0.78M1.34M0.00M0.73M-0.99M0.63M-0.76M0.03M-0.16M0.24M-0.39M-0.17M1.93M-0.02M-1.20M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.05M-0.05M0.42M-0.14M-0.15M-0.15M0.04M-0.12M-0.13M-0.13M-0.28M-0.12M-0.13M-0.13M-0.13M-0.14M-0.14M-0.13M0.07M
Other Working Capital ChangesOther WC Changes
-0.08M-1.92M0.68M0.84M0.64M-1.49M0.04M-0.85M0.87M-0.76M0.48M-0.15M0.04M-0.37M0.26M0.04M-2.06M-0.11M1.27M
Cash from OperationsCash from Ops.
-4.46M-6.89M-5.24M-8.05M-7.10M-9.38M-6.89M-10.82M-7.20M-8.81M-7.42M-8.44M-6.20M-6.57M-5.81M-8.62M-8.89M-10.24M-10.57M
Investing Activities
Capital ExpendituresCapex
0.71M0.39M0.50M0.17M0.64M0.22M0.28M0.14M0.17M0.10M0.05M0.01M0.01M0.00M0.00M0.03M0.14M0.41M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.16M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.71M-0.39M-0.50M-0.17M-0.64M-0.22M-0.28M0.02M-0.17M-0.10M-0.03M-0.01M-0.01M0.00M0.00M-0.03M-0.14M-0.41M
Sale and Maturity of InvestmentsInvestments Sold
Cash from Investing ActivitiesCash from Investing
-0.71M-0.39M-0.50M-0.17M-0.64M-0.22M-0.28M0.02M-0.17M-0.10M-0.03M-0.01M-0.01M0.00M0.00M-0.03M-0.12M-0.41M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
19.91M
Long-Term Debt RepaymentsLT Debt Repayment
1.67M2.50M2.50M2.50M2.50M2.50M2.50M4.23M
Non-Current Debt
19.91M-1.67M-2.50M-2.50M-2.50M-2.50M-2.50M-2.50M-4.23M
Net Debt Issuances and RepaymentsNet Debt Issuance
19.91M-1.67M-2.50M-2.50M-2.50M-2.50M-2.50M-2.50M-4.23M
Change in Capital Stock
Common Stock IssuedStock Issued
0.33M71.36M0.01M0.02M0.04M0.41M4.45M4.18M-7.35M0.63M-0.14M19.39M-5.03M
Net Shares Issued and RepurchasedNet Shares Issued
0.33M71.36M0.01M0.02M0.04M0.41M4.45M4.18M-7.35M0.63M-0.14M19.39M-5.03M
Net Equity Issued and RepurchasedNet Equity Issued
0.33M71.36M0.01M0.02M0.04M0.41M4.45M4.18M-7.35M0.63M-0.14M19.39M-5.03M
Other financing activitiesOther financing
0.18M
Cash from Financing ActivitiesCash from Financing
0.33M71.36M19.92M0.02M0.04M-0.12M-1.26M1.95M1.68M91.91M-1.87M17.44M-3.37M43.90M
Additional items
Change in Cash
-4.84M64.07M-5.74M11.69M-7.71M1.64M-18.36M-10.80M-7.36M-8.91M-7.57M-9.70M-4.26M-4.90M86.10M-10.49M8.52M-13.72M32.92M
Ending Cash Balance
24.74M88.81M83.07M94.76M87.05M77.45M70.32M59.52M52.16M43.25M35.68M25.98M21.72M16.82M102.92M92.43M100.95M87.23M120.15M201.98M
Free Cash FlowFCF
-5.17M-7.29M-5.74M-8.22M-7.73M-9.60M-7.16M-10.96M-7.36M-8.91M-7.47M-8.45M-6.20M-6.57M-5.82M-8.62M-8.92M-10.38M-10.98M
Net Cash FlowNCF
-4.84M64.07M-5.74M11.69M-7.71M-9.60M-7.13M-10.80M-7.36M-8.91M-7.57M-9.70M-4.26M-4.90M86.10M-10.49M8.52M-13.72M32.92M
Interest Paid
0.12M0.21M0.52M0.31M0.50M0.54M0.56M0.56M0.55M0.49M0.42M0.33M0.25M0.19M0.13M0.71M
Income Taxes PaidTaxes Paid
0.02M0.01M0.00M0.09M0.05M0.02M0.03M

Candel Therapeutics Cash Flow Statement API

Pull Candel Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CADL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY